Medical Training AINuclear Medicine Imaging Interpretation
Interpret PET, SPECT, and scintigraphy studies with a clear framework for tracer selection, protocol choice, and pattern recognition across oncology, cardiology, and neurology.
What this track covers
This track covers molecular imaging modalities from conventional scintigraphy through PET/CT and theranostics. It focuses on matching the right study and radiotracer to the clinical question, recognizing normal variants versus pathologic uptake, and integrating findings into oncologic, cardiac, and endocrine workups.
What you will practice
- Match clinical indications to the appropriate nuclear medicine study and radiotracer
- Differentiate normal physiologic uptake from pathologic findings on FDG-PET
- Interpret myocardial perfusion SPECT for ischemia versus infarct patterns
- Read three-phase bone scans for infection, fracture, or metastatic disease
- Evaluate thyroid uptake and scan findings to guide further workup
Simulator scenario
A patient with known malignancy presents for a surveillance PET/CT showing an incidental focal uptake area, and the clinician must decide whether further workup is warranted.
Board question topics
- FDG-PET oncologic staging pitfalls
- Myocardial perfusion SPECT pattern recognition
- Three-phase bone scan interpretation
- Thyroid uptake and scan findings
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free